Airfinity is proud to announce it has been selected as the winning company of the Financial Times’ Tech Champions 2023, in the healthcare category.
The award was looking for tech companies which have risen to the challenges and opportunities presented by new global risks, economic headwinds, geopolitical crises and disruptive AI.
At the forefront of innovation in life sciences, Airfinity tracks, predicts and simulates population level disease outcomes in real time. Our aim is to use data to help leaders make better informed decisions that can increase the global life span.
The awards highlighted Airfinity’s work during the COVID-19 pandemic, on forecasting the ‘tripledemic’ impact of COVID, flu and RSV on healthcare systems, as well as our global surveillance of infectious diseases and our new team analyzing the breakthrough obesity drug market.
Airfinity’s CEO and founder Rasmus Bech Hansen says, “I am grateful to the Financial Times for this award and for telling part of my own personal story in today’s profile.
“As Sir John Bell puts it in the article Airfinity delivered ‘Probably the most expansive, accurate and helpful of the multiple data sets on an international scale’ during the pandemic, something the team can rightly be proud of.
“Importantly, a recognition like this helps attract the talent and partners needed to go much further. Global health challenges cannot be solved without better data. Just like an individual needs the right diagnosis and cure, the entire population needs big data and analytics for effective diagnosis on a larger scale.”